Transmission studies resume for avian flu

Influenza scientists this week announce their intention to resume research into H5N1 avian influenza virus transmission in countries in which governments and institutions have given approval and in which appropriate biosafety and biosecurity conditions have been met. The announcement is published jointly in the journals Nature and Science.

At present scientists are abiding by a voluntary moratorium on research involving highly pathogenic avian influenza H5N1 viruses leading to the generation of viruses that are transmissible in mammals. The moratorium was initiated by influenza researchers from around the world last year after two papers, submitted to Nature and Science by the groups of Yoshihiro Kawaoka, Ron Fouchier and their colleagues, respectively, raised concerns. They chose to halt research for 60 days and later extended the break, citing the need to explain the public-health benefits of the work and describe measures to minimise possible risks, and to enable organisations and governments to review their policies regarding these experiments. The Correspondence states that the signatories believe the aims of the voluntary moratorium have been met in some countries and are close to being met in others, and that avian-flu researchers have a public-health responsibility to resume their research.

There is an accompanying Nature Editorial commenting on this Correspondence.

A copy of the Correspondence and the Nature Editorial can be viewed on the Nature press site.

Corresponding authors:
Yoshihiro Kawaoka (University of Tokyo, Japan; and University of Wisconsin-Madison, WI, USA)
E-mail: [email protected]

Ron Fouchier (Erasmus MC, Rotterdam, The Netherlands)
E-mail: [email protected]

Adolfo García-Sastre (Mount Sinai Hospital, New York, NY, USA)
E-mail: [email protected]

Alternative contacts:
Alice Henchley (Nature London)
Tel: +44 20 7843 4562; E-mail: [email protected]

Rachel Twinn (Nature London)
Tel: +44 20 7843 4658; E-mail: [email protected]

Neda Afsarmanesh (Nature New York)
Tel: +1 212 726 9231; E-mail: [email protected]

Eiji Matsuda (Nature Tokyo)
Tel: +81 3 3267 8751; E-mail: [email protected]

Special Note:

The journals Nature and Science are jointly publishing a Correspondence, signed by numerous researchers, declaring a resumption of research involving avian influenza H5N1 viruses. Please refer also to the Science Press Package on EurekAlert! at www.eurekalert.org/jrnls/sci/ or contact the SciPak team at +1 202 326 6440 or [email protected].

About Nature Publishing Group (NPG):

Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.

Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com